ArticleFrontiers in oncology2025
Tislelizumab-induced type 1 diabetic ketoacidosis in a patient with small cell lung cancer: a case report.
Jie Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this paperpooled itcites it